New autism therapy shows surprising benefits even in adult mice
Blocking the glycine transporter SLC6A20 restored important brain signaling and improved social, communication, and repetitive behaviors in autism-related mouse models. The treatment also worked in human brain organoids and showed lasting effects in adult mice, suggesting the brain may remain more treatable later in life than previously thought.
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
A new wearable patch may help people reach REM sleep faster and remain there longer without medication or surgery. In a …
Over 1 million people a year die from diarrheal disease. Nearly half are kids under age 5. A new vaccine in trials offer…
Mosquitoes aren't just annoying - they kill around 700,000 people a year via the diseases they spread. But scientists ar…
Genetic changes may set off a chain reaction that causes the spine’s natural shock absorbers to harden and deteriorate. …